The present invention relates to compounds of formulas (IA), (IB), and (IC):
the preparation thereof, pharmaceutical formulations thereof, and their use in medicine as allosteric adenosine receptor modulators for uses including protection against hypoxia and ischemia induced injury and treatment of adenosine-sensitive cardiac arrhythmias.
本发明涉及式(Ia)、(Ib)和(Ic)的化合物:其制备、药物制剂以及它们在医学上作为变构
腺苷受体调节剂的用途,包括保护免受缺氧和缺血引起的损伤和治疗
腺苷敏感性心律失常。